Literature DB >> 16382880

Cancer stem cells--normal stem cells "Jedi" that went over to the "dark side".

Mariusz Z Ratajczak1.   

Abstract

Evidence has accumulated that cancer develops from a population of quiescent tissue committed/pluripotent stem cells (TCSC/PSC) or cells developmentally closely related to them that are distributed in various organs. To support this notion, stem cells (SC) are long lived cells and thus may become the subject of accumulating mutations that are crucial for initiation/progression of cancer. More important, they may maintain these mutations and pass them to the daughter stem cells. Therefore, mutations that occur in normal SC, accumulate during the life of an organism at the clonal level in the stem cell compartment committed to a given tissue/organ. As a consequence, this may lead to the malignant transformation of SC and tumor initiation. Furthermore, many biological features of normal and cancer SC such as the physiological trafficking of normal and metastasis of cancer stem cells involve similar molecular mechanisms, and we discuss these similarities here. Therefore, looking both at the origin and behavioral aspects we can envision cancer SC being normal SC "Jedi" that went over to the "dark side".

Entities:  

Mesh:

Year:  2005        PMID: 16382880

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  21 in total

Review 1.  Development of cancer-initiating cells and immortalized cells with genomic instability.

Authors:  Ken-Ichi Yoshioka; Yuko Atsumi; Hitoshi Nakagama; Hirobumi Teraoka
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

2.  A Tangeretin Derivative Inhibits the Growth of Human Prostate Cancer LNCaP Cells by Epigenetically Restoring p21 Gene Expression and Inhibiting Cancer Stem-like Cell Proliferation.

Authors:  Guor-Jien Wei; Yen-Hsiang Chao; Yen-Chen Tung; Tien-Yuan Wu; Zheng-Yuan Su
Journal:  AAPS J       Date:  2019-07-10       Impact factor: 4.009

3.  Chemotherapy sorting can be used to identify cancer stem cell populations.

Authors:  Liping Li; Bingkun Li; Jialiang Shao; Xiang Wang
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

4.  Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.

Authors:  Raheleh Roudi; Zahra Madjd; Marzieh Ebrahimi; Ali Najafi; Alireza Korourian; Ahmad Shariftabrizi; Ali Samadikuchaksaraei
Journal:  Tumour Biol       Date:  2016-04-05

5.  Formation of spherical cancer stem-like cell colonies with resistance to chemotherapy drugs in the human malignant fibrous histiocytoma NMFH-1 cell line.

Authors:  Liang Deng; Dejian Li; Wenguang Gu; Aiguo Liu; Xiangyang Cheng
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

Review 6.  Cancer stem cells and cancer therapy.

Authors:  Sara Soltanian; Maryam M Matin
Journal:  Tumour Biol       Date:  2011-02-12

7.  Newer insights into premeiotic development of germ cells in adult human testis using Oct-4 as a stem cell marker.

Authors:  Deepa Bhartiya; Sandhya Kasiviswanathan; Sreepoorna K Unni; Prasad Pethe; Jayesh V Dhabalia; Sujata Patwardhan; Hemant B Tongaonkar
Journal:  J Histochem Cytochem       Date:  2010-08-30       Impact factor: 2.479

Review 8.  CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

9.  Side population cells from long-term passage non-small cell lung cancer cells display loss of cancer stem cell-like properties and chemoradioresistance.

Authors:  Hao Gu; Xin-Yu Wu; Rui-Tai Fan; Xin Wang; You-Zhong Guo; Rui Wang
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

10.  Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics.

Authors:  Marion Gilormini; Anne-Sophie Wozny; Priscillia Battiston-Montagne; Dominique Ardail; Gersende Alphonse; Claire Rodriguez-Lafrasse
Journal:  J Vis Exp       Date:  2016-05-11       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.